ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Uplizna 100 mg/10ml, Konzentrat zur Herstellung einer Infusionslösung - 3
69322001 Horizon Therapeutics Switzerland GmbH
Uplizna 100 mg/10ml, Konzentrat zur Herstellung einer Infusionslösung04.03.2024
  04.03.2024
Inebilizumab (L04AA47) 
WHO-DDD03.03.2029
3
07.15. 
A  
No 
  
PR  
k.A.PR
  
7680693220010Biotechnologika
  
Composition
inebilizumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, natrii chloridum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 10 ml corresp., natrium 16.1 mg.
Packungsbestandteile
Concentrate for infusion
 
 
Active AgentDose
Inebilizumabum100mg / 10ml
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Sodium Chloride
Polysorbatum 80
Trehalosum Dihydricum
Source
Data was imported : 04.04.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home